A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age
- Status
- COMPLETED
- Phase
- PHASE1
Related studies linked through entity extraction aliases.